無料セミナー : 2020年3月4日『Future of Immuno-Oncology 免疫腫瘍学の未来』 DelveInsight Business Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CRISPR/Cas遺伝子市場 - 世界市場規模、シェア、発展、成長、需要予測(2018~2026年)

CRISPR and Cas Genes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

発行 Transparency Market Research 商品コード 719542
出版日 ページ情報 英文 200 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
CRISPR/Cas遺伝子市場 - 世界市場規模、シェア、発展、成長、需要予測(2018~2026年) CRISPR and Cas Genes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日: 2018年09月03日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界のCRISPR/Cas遺伝子市場について調査し、市場の現状と2026年までの成長予測、セグメント別動向、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 動向

第5章 製品別市場分析と予測

  • イントロダクションと定義
  • 市場価値予測
    • ベクターベース
    • DNAフリー
  • 市場の魅力度

第6章 用途別市場分析と予測

  • イントロダクションと定義
  • 市場価値予測
    • ゲノムエンジニアリング
    • 疾患モデル
    • 機能的ゲノミクス
    • ノックダウン/アクチベーション
  • 市場の魅力度

第7章 エンドユーザー別市場分析と予測

  • イントロダクションと定義
  • 市場価値予測
    • バイオテクノロジー・製薬会社
    • 学術・政府研究機関
    • CRO
  • 市場の魅力度

第8章 地域別市場分析と予測

  • 主な調査結果
  • 市場価値予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度

第9章 北米市場

第10章 欧州市場

第11章 アジア太平洋地域市場

第12章 ラテンアメリカ市場

第13章 中東・アフリカ市場

第14章 競合環境

  • 競合マトリクス
  • 市場シェア分析
  • 企業プロファイル
    • Synthego
    • Thermo Fisher Scientific, Inc.
    • GenScript
    • Addgene
    • Merck KGaA (Sigma-Aldrich)
    • Integrated DNA Technologies, Inc.
    • Transposagen Biopharmaceuticals, Inc.
    • OriGene Technologies, Inc.
    • New England Biolabs
    • Dharmacon, a Horizon Discovery Group Co.
    • Cellecta, Inc.
    • Agilent Technologies
    • Applied StemCell, Inc.
図表

List of Tables

  • Table 01: Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 02: Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 03: Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 04: Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Region, 2016-2026
  • Table 05: North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country, 2016-2026
  • Table 06: North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 07: North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application Type, 2016-2026
  • Table 08: North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 09: Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 10: Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 11: Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 12: Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 13: Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 14: Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 15: Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application Type, 2016-2026
  • Table 16: Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 17: Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 18: Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 19: Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application Type, 2016-2026
  • Table 20: Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 21: Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 22: Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Product, 2016-2026
  • Table 23: Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by Application, 2016-2026
  • Table 24 : Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast, by End-user, 2016-2026

List of Figures

  • Figure 01: Global CRISPR and Cas Genes Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 02: Market Snapshot
  • Figure 03: Opportunity Map, 2017
  • Figure 04: Opportunity Map, 2017
  • Figure 05: Opportunity Map, 2017
  • Figure 06: Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 07: Global CRISPR and Cas Genes Market Value Share, by Product, 2017
  • Figure 08: Global CRISPR and Cas Genes Market Value Share, by Application, 2017
  • Figure 09: Global CRISPR and Cas Genes Market Value Share, by End-user, 2017
  • Figure 10: Global CRISPR and Cas Genes Market Value Share, by Region, 2017
  • Figure 11: Global CRISPR and Cas Genes Market Value Share, by Product, 2017 and 2026
  • Figure 12: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vector-based Cas, 2016-2026
  • Figure 13: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA-free Cas, 2016-2026
  • Figure 14: Global CRISPR and Cas Genes Market Attractiveness Analysis, by Product, 2018-2026
  • Figure 15: Global CRISPR and Cas Genes Market Value Share, by Application, 2017 and 2026
  • Figure 16: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Genome Engineering, 2016-2026
  • Figure 17: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Disease Models, 2016-2026
  • Figure 18: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2016-2026
  • Figure 19: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016-2026
  • Figure 20: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Functional Genomics, 2016-2026
  • Figure 21: Global CRISPR and Cas Genes Market Attractiveness Analysis, by Application, 2018-2026
  • Figure 22: Global CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 23: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2016-2026
  • Figure 24: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Government Research Institutes, 2016-2026
  • Figure 25: Global CRISPR and Cas Genes Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016-2026
  • Figure 26: Global CRISPR and Cas Genes Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 27: Global CRISPR and Cas Genes Market Value Share, by Region, 2017 and 2026
  • Figure 28: Global CRISPR and Cas Genes Market Attractiveness Analysis, by Region, 2018-2026
  • Figure 29: North America CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 30: North America CRISPR and Cas Genes Market Value Share, by Country, 2017 and 2026
  • Figure 31: North America CRISPR and Cas Genes Market Attractiveness, by Country, 2018-2026
  • Figure 32: North America CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 33: North America CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018-2026
  • Figure 34: North America CRISPR and Cas Genes Market Value Share, by Application Type, 2017 and 2026
  • Figure 35: North America CRISPR and Cas Genes Market Attractiveness, by Application Type, 2018-2026
  • Figure 36: North America CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 37: North America CRISPR and Cas Genes Market Attractiveness, by End-user, 2018-2026
  • Figure 38: Europe CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 39: Europe CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 40: Europe CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 41: Europe CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 42: Europe CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018-2026
  • Figure 43: Europe CRISPR and Cas Genes Market Value Share, by Application, 2017 and 2026
  • Figure 44: Europe CRISPR and Cas Genes Market Attractiveness, by Application, 2018-2026
  • Figure 45: Europe CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 46: Europe CRISPR and Cas Genes Market Attractiveness, by End-user, 2018-2026
  • Figure 47: Asia Pacific CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 48: Asia Pacific CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 49: Asia Pacific CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 50: Asia Pacific CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 51: Asia Pacific CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018-2026
  • Figure 52: Asia Pacific CRISPR and Cas Genes Market Value Share, by Application Type, 2017 and 2026
  • Figure 53: Asia Pacific CRISPR and Cas Genes Market Attractiveness, by Application Type, 2018-2026
  • Figure 54: Asia Pacific CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 55: Asia Pacific CRISPR and Cas Genes Market Attractiveness, by End-user, 2018-2026
  • Figure 56: Latin America CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 57: Latin America CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 58: Latin America CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 59: Latin America CRISPR and Cas Genes Market Value Share, by Product Type, 2017 and 2026
  • Figure 60: Latin America CRISPR and Cas Genes Market Attractiveness, by Product Type, 2018-2026
  • Figure 61: Latin America CRISPR and Cas Genes Market Value Share, by Application Type, 2017 and 2026
  • Figure 62: Latin America CRISPR and Cas Genes Market Attractiveness, by Application Type, 2018-2026
  • Figure 63: Latin America CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 64: Latin America CRISPR and Cas Genes Market Attractiveness, by End-user, 2018-2026
  • Figure 65: Middle East & Africa CRISPR and Cas Genes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 66: Middle East & Africa CRISPR and Cas Genes Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 67: Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 68: Middle East & Africa CRISPR and Cas Genes Market Value Share, by Product, 2017 and 2026
  • Figure 69: Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by Product, 2018-2026
  • Figure 70: Middle East & Africa CRISPR and Cas Genes Market Value Share, by Application, 2017 and 2026
  • Figure 71: Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by Application, 2018-2026
  • Figure 72: Middle East & Africa CRISPR and Cas Genes Market Value Share, by End-user, 2017 and 2026
  • Figure 73: Middle East & Africa CRISPR and Cas Genes Market Attractiveness, by End-user, 2018-2026
  • Figure 74: Thermo Fisher Scientific Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2017
  • Figure 75: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Region, 2017
  • Figure 76: Thermo Fisher Scientific Inc. Breakdown of Net Sales, by Business Segment, 2017
  • Figure 77: Thermo Fisher Scientific Inc. R&D Expense (US$ Mn) and Y-o-Y Growth (%), 2013-2017
  • Figure 78: GenScript Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 79: GenScript Breakdown of Net Sales, by Region, 2017
  • Figure 80: GenScript Breakdown of Net Sales, by Business Segment, 2017
  • Figure 81: GenScript R&D Expense (US$ Mn) and Selling and Distribution (US$ Mn), 2016-2017
  • Figure 82: Merck KGaA (Sigma Aldrich) Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2017
  • Figure 83: Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Region, 2017
  • Figure 84: Merck KGaA (Sigma Aldrich) Breakdown of Net Sales, by Business Segment, 2017
  • Figure 85: Merck KGaA (Sigma Aldrich) Research & Development Market Share (%), by Business Segment, 2017
  • Figure 86: Agilent Technologies Breakdown of Net Sales, by Region, 2017
  • Figure 87: Agilent Technologies Breakdown of Net Sales (US$ Mn), by Segment, 2017
  • Figure 88: Agilent Technologies Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
目次

Title:
CRISPR and Cas Genes Market (Product - Vector-based Cas, DNA-free Cas; Application - Genome Engineering, Disease Models, Functional Genomics, Knockdown/Activation; End use - Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global CRISPR and Cas Genes Market: Overview

This report analyzes the current and future scenario of the global CRISPR and Cas genes market. Rise in government spending in research and development of genome editing, increase in incidence of genetic disorders, and usage of CRISPR/Cas9 technology to improve crop production are factors driving the global market. The global CRISPR and Cas genes market has been segmented based on product, application, end-user, and region.

The global CRISPR and Cas genes market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global CRISPR and Cas genes market.

Global CRISPR and Cas Genes Market: Key Segments

Based on product, the global CRISPR and Cas genes market has been segmented into vector-based Cas and DNA-free Cas. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of application, the global CRISPR and Cas genes market has been classified into genome engineering, disease models, functional genomics, knockout/activation, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on end-user, the global CRISPR and Cas genes market has been divided into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global CRISPR and Cas Genes Market: Regional Outlook

The global CRISPR and Cas genes market has been segmented into five major regions: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players operating in the global CRISPR and Cas genes market include Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck KGaA (Sigma-Aldrich), Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc., New England Biolabs, Dharmacon, Cellecta, Inc., Agilent Technologies, and Applied StemCell Inc. These players are adopting organic and in-organic growth strategies to expand product offerings, strengthen geographical reach, increase customer base, and market share.

The global CRISPR and Cas genes market has been segmented as follows:

Global CRISPR and Cas Genes Market, by Product

  • Vector-based Cas
  • DNA-free Cas

Global CRISPR and Cas Genes Market, by Application

  • Genome Engineering
  • Disease Models
  • Functional Genomics
  • Knockdown/activation
  • Others

Global CRISPR and Cas Genes Market, by End-user

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations

Global CRISPR and Cas Genes Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global CRISPR and Cas Genes Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
    • 4.2.1. Global CRISPR and Cas Genes Market Size (US$ Mn) Forecast, 2016-2026
    • 4.2.2. Global CRISPR and Cas Genes Market Outlook
    • 4.2.3. Evolution of CRISPRs
    • 4.2.4. Research institutes involved in CRISPR Research
    • 4.2.5. CRISPR: Funding & Investment
    • 4.2.7. Mergers and Acquisitions
  • 4.3. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunities

5. Global CRISPR and Cas Genes Market Analysis and Forecasts, by Product

  • 5.1. Introduction & Definition
  • 5.2. Market Value Forecast, by Product, 2016-2026
    • 5.2.1. Vector-based Cas
    • 5.2.2. DNA-free Cas
  • 5.3. Market Attractiveness, by Product

6. Global CRISPR and Cas Genes Market Analysis and Forecasts, by Application

  • 6.1. Introduction & Definition
  • 6.2. Market Value Forecast, by Application, 2016-2026
    • 6.2.1. Genome Engineering
    • 6.2.2. Disease Models
    • 6.2.3. Functional Genomics
    • 6.2.4. Knockdown/activation
    • 6.2.5. Others
  • 6.3. Market Attractiveness, by Application

7. Global CRISPR and Cas Genes Market Analysis and Forecasts, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Market Value Forecast, by End-user, 2016-2026
    • 7.2.1. Biotechnology & Pharmaceutical Companies
    • 7.2.2. Academic & Government Research Institutes
    • 7.2.3. Contract Research Organizations
  • 7.3. Market Attractiveness, by End-user

8. Global CRISPR and Cas Genes Market Analysis and Forecasts, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Country/Region

9. North America CRISPR and Cas Genes Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Market Value Forecast, by Product, 2016-2026
    • 9.2.1. Vector-based Cas
    • 9.2.2. DNA-free Cas
  • 9.3. Market Value Forecast, by Application, 2016-2026
    • 9.3.1. Genome Engineering
    • 9.3.2. Disease Models
    • 9.3.3. Functional Genomics
    • 9.3.4. Knockdown/activation
    • 9.3.5. Others
  • 9.4. Market Value Forecast, by End-user, 2016-2026
    • 9.4.1. Biotechnology & Pharmaceutical Companies
    • 9.4.2. Academic & Government Research Institutes
    • 9.4.3. Contract Research Organizations
  • 9.5. Market Value Forecast, by Country, 2016-2026
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Product
    • 9.6.2. By Application
    • 9.6.3. By End-user
    • 9.6.4. By Country

10. Europe CRISPR and Cas Genes Market Analysis and Forecast

  • 10.1.Introduction
  • 10.2.Market Value Forecast, by Product, 2016-2026
    • 10.2.1. Vector-based Cas
    • 10.2.2. DNA-free Cas
  • 10.3.Market Value Forecast, by Application, 2016-2026
    • 10.3.1. Genome Engineering
    • 10.3.2. Disease Models
    • 10.3.3. Functional Genomics
    • 10.3.4. Knockdown/activation
    • 10.3.5. Others
  • 10.4.Market Value Forecast, by End-user, 2016-2026
    • 10.4.1. Biotechnology & Pharmaceutical Companies
    • 10.4.2. Academic & Government Research Institutes
    • 10.4.3. Contract Research Organizations
  • 10.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Spain
    • 10.5.5. Italy
    • 10.5.6. Rest of Europe
  • 10.6.Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country/Sub-region

11. Asia Pacific CRISPR and Cas Genes Market Analysis and Forecast

  • 11.1.Introduction
  • 11.2.Market Value Forecast, by Product, 2016-2026
    • 11.2.1. Vector-based Cas
    • 11.2.2. DNA-free Cas
  • 11.3.Market Value Forecast, by Application, 2016-2026
    • 11.3.1. Genome Engineering
    • 11.3.2. Disease Models
    • 11.3.3. Functional Genomics
    • 11.3.4. Knockdown/activation
    • 11.3.5. Others
  • 11.4.Market Value Forecast, by End-user, 2016-2026
    • 11.4.1. Biotechnology & Pharmaceutical Companies
    • 11.4.2. Academic & Government Research Institutes
    • 11.4.3. Contract Research Organizations
  • 11.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 11.5.1. Japan
    • 11.5.2. China
    • 11.5.3. India
    • 11.5.4. Rest of Asia Pacific
  • 11.6.Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Latin America CRISPR and Cas Genes Market Analysis and Forecast

  • 12.1.Introduction
  • 12.2.Market Value Forecast, by Product, 2016-2026
    • 12.2.1. Vector-based Cas
    • 12.2.2. DNA-free Cas
  • 12.3.Market Value Forecast, by Application, 2016-2026
    • 12.3.1. Genome Engineering
    • 12.3.2. Disease Models
    • 12.3.3. Functional Genomics
    • 12.3.4. Knockdown/activation
    • 12.3.5. Others
  • 12.4.Market Value Forecast, by End-user, 2016-2026
    • 12.4.1. Biotechnology & Pharmaceutical Companies
    • 12.4.2. Academic & Government Research Institutes
    • 12.4.3. Contract Research Organizations
  • 12.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6.Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Middle East & Africa CRISPR and Cas Genes Market Analysis and Forecast

  • 13.1.Introduction
  • 13.2.Market Value Forecast, by Product, 2016-2026
    • 13.2.1. Vector-based Cas
    • 13.2.2. DNA-free Cas
  • 13.3.Market Value Forecast, by Application, 2016-2026
    • 13.3.1. Genome Engineering
    • 13.3.2. Disease Models
    • 13.3.3. Functional Genomics
    • 13.3.4. Knockdown/activation
    • 13.3.5. Others
  • 13.4.Market Value Forecast, by End-user, 2016-2026
    • 13.4.1. Biotechnology & Pharmaceutical Companies
    • 13.4.2. Academic & Government Research Institutes
    • 13.4.3. Contract Research Organizations
  • 13.5.Market Value Forecast, by Country/Sub-region, 2016-2026
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6.Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Competition Landscape

  • 14.1.Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2.Market Share Analysis, by Company (2015)
  • 14.3.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 14.3.1. Synthego
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Thermo Fisher Scientific, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. GenScript
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.4. Addgene
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Merck KGaA (Sigma-Aldrich)
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Integrated DNA Technologies, Inc.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Transposagen Biopharmaceuticals, Inc.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. OriGene Technologies, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. New England Biolabs
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Dharmacon, a Horizon Discovery Group Co.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Cellecta, Inc.
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Financial Overview
      • 14.3.11.3. Product Portfolio
      • 14.3.11.4. SWOT Analysis
      • 14.3.11.5. Strategic Overview
    • 14.3.12. Agilent Technologies
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. Product Portfolio
      • 14.3.12.4. SWOT Analysis
      • 14.3.12.5. Strategic Overview
    • 14.3.13. Applied StemCell, Inc.
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Financial Overview
      • 14.3.13.3. Product Portfolio
      • 14.3.13.4. SWOT Analysis
      • 14.3.13.5. Strategic Overview
Back to Top